Article | July 15, 2024

CAR T Set The Pace So All Can Win The Cell Therapy Race

Source: Cytiva
Getty Images-823447656-vector-viral-lab-AAV-cell-development

The critical function of cells in disease has been recognized for centuries, but it has only been in the past century that scientists have explored the potential of cells as a treatment option. From the initial stem cell transplants to the current pipeline of advanced cell therapies, researchers and manufacturers have set the foundation for today's significant achievements in medicine.

Gain insight into the modest origins of cell therapy manufacturing and how this history has paved the way for future advancements from Bill Shingleton, R&D Leader at Cytiva. Explore the past of building workflows to support CAR T cell therapy, the present of welcoming new cell types to cell therapy, and the future of optimizing cell therapy processes for both efficiency and accessibility.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Biosimilar Development? Subscribe today.

Subscribe to Biosimilar Development X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Biosimilar Development